Bispecific binding agents binding to cldn18.2 and cd3
US-2026035458-A1 · Feb 5, 2026 · US
This page is not indexed by search engines while we improve data quality.
Moore Gregory patents
Moore Gregory is listed as an inventor on 146 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Moore Gregory |
| Total patents | 146 |
| First publication | Oct 13, 2015 |
| Latest publication | Feb 5, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Anti-cd28 x anti-psma antibodies
US-2025388704-A1 · Dec 25, 2025 · US
Bispecific checkpoint inhibitor antibodies
US-2025333519-A1 · Oct 30, 2025 · US
Targeted heterodimeric Fc fusion proteins containing NKG2D antigen binding domains
US-12448423-B2 · Oct 21, 2025 · US
Heterodimeric antibodies that bind cd3 and tumor antigens
US-2025304724-A1 · Oct 2, 2025 · US
Heterodimeric proteins
US-12415849-B2 · Sep 16, 2025 · US
Bispecific binding agents binding to CLDN18.2 and CD3
US-12378313-B2 · Aug 5, 2025 · US
Anti-CD28 x anti-PSMA antibodies
US-12378326-B2 · Aug 5, 2025 · US
Anti-CD28 x anti-PSMA antibodies
US-12365743-B2 · Jul 22, 2025 · US
Heterodimeric antibodies that bind CD3 and tumor antigens
US-12359002-B2 · Jul 15, 2025 · US
Recent patents
Latest publications not already listed above.
Anti-cd20 antibodies and therapeutic uses thereof
US-2025197519-A1 · Jun 19, 2025 · US
Anti-steap1 antigen-binding protein
US-2025154281-A1 · May 15, 2025 · US
Heterodimeric antibodies that bind cd3 and tumor antigens
US-2025109215-A1 · Apr 3, 2025 · US
Heterodimeric antibodies that bind cd3 and cd38
US-2025109214-A1 · Apr 3, 2025 · US
Anti-cd28 x anti-enpp3 antibodies
US-2025084186-A1 · Mar 13, 2025 · US
Anti-cd28 x anti-trop2 antibodies
US-2025084179-A1 · Mar 13, 2025 · US
Anti-cd28 compositions
US-2025043001-A1 · Feb 6, 2025 · US
Optimized antibody variable regions
US-2025034247-A1 · Jan 30, 2025 · US
B-cell maturation antigen (bcma) binding domain compositions
US-2024392025-A1 · Nov 28, 2024 · US
Bispecific and monospecific antibodies using novel anti-PD-1 sequences
US-12152076-B2 · Nov 26, 2024 · US
Orthogonal multimeric proteins
US-2024360220-A1 · Oct 31, 2024 · US
Heterodimeric antibodies that bind CD3 and CD38
US-12129309-B2 · Oct 29, 2024 · US
Anti-steap1 antigen-binding protein
US-2024301087-A1 · Sep 12, 2024 · US
Heterodimeric antibodies that bind somatostatin receptor 2
US-12054545-B2 · Aug 6, 2024 · US
Heterodimeric antibodies that bind claudin18.2 and cd3
US-2024247062-A1 · Jul 25, 2024 · US
Anti-cd28 x anti-psma antibodies
US-2024218082-A1 · Jul 4, 2024 · US
Untargeted and targeted IL-10 Fc-fusion proteins
US-12006345-B2 · Jun 11, 2024 · US
Il18-fc fusion proteins
US-2024166705-A1 · May 23, 2024 · US
Heterodimeric antibodies that bind CD3 and tumor antigens
US-11945880-B2 · Apr 2, 2024 · US
Heterodimeric proteins
US-2024092871-A1 · Mar 21, 2024 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Xencor Inc | 145 |
| Janssen Biotech Inc | 6 |
| Amgen Inc | 5 |
| Astellas Pharma Europe Bv | 4 |
| Bank Of America | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K2317/31 | 128 |
| C07K2317/622 | 126 |
| C07K16/2809 | 111 |
| A61K2039/505 | 106 |
| C07K2317/55 | 104 |